HDFC Pharma and Healthcare Fund - Growth Option

  • Scheme Category:  
  • Equity Scheme >  
  • Sectoral/Thematic Funds
NAV: ₹ 18.242 ↓ -0.01%
[as on 30 April, 2026]

NAV chart

SMA (Simple Moving Average)

  • 50 SMA
  • 100 SMA
  • 200 SMA
  • 400 SMA

Returns

CAGR returns till date

CAGR returns of HDFC Pharma and Healthcare Fund - Growth Option and its peers as on 30 April, 2026
NameYTD1D1W1M3M1Y3Y5Y7Y10Y
HDFC Pharma and Healthcare Fund - Growth Option 6.18% -0.01% 1.19% 7.44% 10.64% 13.84%----
SBI HEALTHCARE OPPORTUNITIES FUND - REGULAR PLAN -GROWTH 4.34% 0.23% 1.46% 5.71% 8.21% 4.56% 24.91% 15.57% 20.11% 12.33%
SBI ESG Exclusionary Strategy Fund - Regular Plan - Growth -6.52% -0.85% -1.82% 9.73% -3.47% 0.77% 12.26% 11.31% 11.77% 12.07%
SBI INFRASTRUCTURE FUND - REGULAR PLAN - GROWTH 2.05% -0.72% 0.54% 16.66% 6.07% 6.18% 21.02% 21.19% 18.87% 16.1%
SBI PSU Fund - REGULAR PLAN -Growth 5.55% -1.29% -1.52% 9.81% 2.78% 16.42% 30.87% 26.93% 19.71% 15.56%
SBI CONSUMPTION OPPORTUNITIES FUND - REGULAR - GROWTH -5.46% -0.83% -1.06% 10.77% 1.03% -4.44% 11.24% 15.49% 13.84% 14.51%

Discrete returns (yearly)

Year2016201720182019202020212022202320242025
Returns-------- 50.48% 0.54%

Discrete returns (monthly)

MonthJul 2025Aug 2025Sep 2025Oct 2025Nov 2025Dec 2025Jan 2026Feb 2026Mar 2026Apr 2026
Returns 5.23% -1.55% -1.54% 2.06% 1.12% -1.48% -4.75% 6.9% -4.45% 7.74%

Returns from spefic dates

DescriptionCAGR returns from 26 Sep 2024 (Nifty 50 2024 high)
Returns 8.46%

Portfolio

Asset allocation

EquityDebtRealestateCommoditiesCash & Equivalents
98.52% 0.00% (Arbitrage: 0.00%) 0.00% 0.00% 1.48%

Equity

NameSymbol / ISINSectorWeight %
Sun Pharmaceutical Industries Ltd.SUNPHARMA (INE044A01036)Pharmaceuticals & Biotechnology10.20%
Divis Laboratories Ltd.DIVISLAB (INE361B01024)Pharmaceuticals & Biotechnology8.20%
Glenmark Pharmaceuticals Ltd.GLENMARK (INE935A01035)Pharmaceuticals & Biotechnology6.78%
Lupin Ltd.LUPIN (INE326A01037)Pharmaceuticals & Biotechnology6.65%
Alkem Laboratories Ltd.ALKEM (INE540L01014)Pharmaceuticals & Biotechnology5.99%
Max Healthcare Institute LimitedMAXHEALTH (INE027H01010)Healthcare Services5.96%
Aster DM Healthcare LimitedASTERDM (INE914M01019)Healthcare Services5.70%
Ipca Laboratories Ltd.IPCALAB (INE571A01038)Pharmaceuticals & Biotechnology5.16%
Acutaas Chemicals LimitedACUTAAS (INE00FF01025)Pharmaceuticals & Biotechnology4.39%
Anthem Biosciences LimitedANTHEM (INE0CZ201020)Pharmaceuticals & Biotechnology4.29%
Fortis Healthcare LimitedFORTIS (INE061F01013)Healthcare Services3.49%
Krishna Institute Of Medical Sciences LimitedKIMS (INE967H01025)Healthcare Services3.10%
Laurus Labs Ltd.LAURUSLABS (INE947Q01028)Pharmaceuticals & Biotechnology2.76%
Metropolis Healthcare Ltd.METROPOLIS (INE112L01020)Healthcare Services2.37%
Torrent Pharmaceuticals Ltd.TORNTPHARM (INE685A01028)Pharmaceuticals & Biotechnology2.34%
Eris Lifesciences LtdERIS (INE406M01024)Pharmaceuticals & Biotechnology2.24%
Vijaya Diagnostic Centre LimitedVIJAYA (INE043W01024)Healthcare Services2.13%
Sai Life Sciences LimitedSAILIFE (INE570L01029)Pharmaceuticals & Biotechnology2.09%
Shilpa Medicare LtdSHILPAMED (INE790G01031)Pharmaceuticals & Biotechnology1.91%
Global Health LimitedMEDANTA (INE474Q01031)Healthcare Services1.88%
Dr. Lal Path Labs LtdLALPATHLAB (INE600L01024)Healthcare Services1.57%
Neuland Laboratories LimitedNEULANDLAB (INE794A01010)Pharmaceuticals & Biotechnology1.54%
Wockhardt Ltd.WOCKPHARMA (INE049B01025)Pharmaceuticals & Biotechnology1.54%
Jubilant Pharmova LimitedJUBLPHARMA (INE700A01033)Pharmaceuticals & Biotechnology1.31%
Thyrocare Technologies Ltd.THYROCARE (INE594H01019)Healthcare Services1.27%
Rubicon Research LimitedRUBICON (INE506V01022)Pharmaceuticals & Biotechnology1.24%
Gland Pharma Ltd.GLAND (INE068V01023)Pharmaceuticals & Biotechnology1.07%
BAJAJ HEALTHCARE LIMITEDBAJAJHCARE (INE411U01027)Pharmaceuticals & Biotechnology0.83%
Laxmi Dental LimitedLAXMIDENTL (INE0WO601020)Healthcare Equipment & Supplies0.52%
Portfolio data is as on date 31 March, 2026

NAV history

HDFC Pharma and Healthcare Fund - Growth Option - 30 days NAV (Net asset value) history

DateNAV% change
30 April, 202618.242 -0.01%
29 April, 202618.243 0.26%
28 April, 202618.195 -0.39%
27 April, 202618.267 2.31%
24 April, 202617.854 -0.97%
23 April, 202618.028 0.74%
22 April, 202617.895 0.4%
21 April, 202617.823 0.07%
20 April, 202617.811 -0.01%
17 April, 202617.812 0.39%
16 April, 202617.743 0.07%
15 April, 202617.731 1.82%
13 April, 202617.414 -0.5%
10 April, 202617.502 0.67%
9 April, 202617.386 0.95%
8 April, 202617.222 1.78%
7 April, 202616.92 0.39%
6 April, 202616.854 0.57%
2 April, 202616.758 -1.02%
1 April, 202616.931 -0.28%
31 March, 202616.978 -0.01%
30 March, 202616.979 -1.23%
27 March, 202617.191 -0.34%
25 March, 202617.249 1.94%
24 March, 202616.92 1.42%
23 March, 202616.683 -1.85%
20 March, 202616.997 1.15%
19 March, 202616.804 -2.29%
18 March, 202617.198 0.67%
17 March, 202617.083

FAQ (Frequently asked questions)

  • What is latest/current NAV/price of HDFC Pharma and Healthcare Fund - Growth Option?
    The latest NAV of HDFC Pharma and Healthcare Fund - Growth Option is 18.242 as on 30 April, 2026.
  • What are YTD (year to date) returns of HDFC Pharma and Healthcare Fund - Growth Option?
    The YTD (year to date) returns of HDFC Pharma and Healthcare Fund - Growth Option are 6.18% as on 30 April, 2026.
  • What are 1 year returns of HDFC Pharma and Healthcare Fund - Growth Option?
    The 1 year returns of HDFC Pharma and Healthcare Fund - Growth Option are 13.84% as on 30 April, 2026.